Skip to content

To study the effect of oxygen therapy on non-healing leg ulcer.

Effect of oxygen therapy using kadam device on chronic non-healing foot ulcer- a patient preference based multicentric study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/09/021352
Enrollment
100
Registered
2019-09-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L979- Non-pressure chronic ulcer of unspecified part of lower leg

Interventions

Intervention1: Warm oxygen therapy: Warm oxygen therapy using KADAM for 90 minutes at 3 intervals of 30 minutes each given on alternate days for 6 weeks Control Intervention1: NOT APPLICABLE: NOT APPL

Sponsors

Yostra Labs Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with non-healing foot ulcer more than 6 weeks and less than 12 months 2. With any of the following etiology such as diabetic foot ulcers or ulcers with arterial or venous abnormality (or as per investigatorâ??s preference) a) Wagner-Meggitt Grade 2, 3. b) Above 18 years of age c) Of either gender

Exclusion criteria

Exclusion criteria: 1. Foot ulcers of other pathologies 2. Presence of invasive infection requiring intravenous antibiotics 3. Patients not willing to participate in the study 4. Any other medical condition that the investigator feels that the patient may not be eligible for the study

Design outcomes

Primary

MeasureTime frame
To study the effect of KADAM based oxygen therapy on percentage change in ulcer size at the end of 6 weeks To study the compliance and patient preference to KADAM based oxygen therapy To study the effect of KADAM based oxygen therapy on quality of life as measured using EQ-5D-5LTimepoint: 6 weeks

Secondary

MeasureTime frame
To study the effect of KADAM based oxygen Therapy on glycaemic control Amputation, infection and hospitalisation rates over a 6 week follow-up periodTimepoint: 6 weeks

Countries

India

Contacts

Public ContactDr Robbie George

Mazumdar Shaw Medical Centre

drrobbiegeorge@gmail.com9538896751

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026